
Organicell Regenerative Medicine, Inc.
OTC:OCEL
Overview | Financials
Company Name | Organicell Regenerative Medicine, Inc. |
Symbol | OCEL |
Currency | USD |
Price | 0.007 |
Market Cap | 10,051,230 |
Dividend Yield | 0% |
52-week-range | 0.005 - 0.052 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Harry L. Leider FACPE, M.B.A., M.D., MBA |
Website | https://www.organicell.com |
An error occurred while fetching data.
About Organicell Regenerative Medicine, Inc.
Organicell Regenerative Medicine, Inc., a clinical-stage biopharmaceutical company, focuses on the development of biological therapeutics for the treatment of degenerative diseases. Its leading product candidate is Zofin, an acellular, biologic therapeutic derived from perinatal sources and is manufactured to retain naturally occurring microRNAs without the addition or combination of any
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD